Home / Class Action Hub / Bayer / Monsanto
Pharmaceutical / medical device · Active — claim period open

Roundup (Glyphosate) Cancer Settlements

Tens of thousands of cancer claims by people exposed to glyphosate-based herbicide.

Settlement total
$11.0B
Estimated payout
Varies
Claim deadline
Status
Active — claim period open

About the case

Bayer (which acquired Monsanto) has paid approximately $11 billion to resolve roughly 100,000 Roundup cancer claims, with additional cases pending. Plaintiffs allege that exposure to glyphosate caused non-Hodgkin's lymphoma and other cancers. Cases continue to be filed; settlement amounts vary based on diagnosis severity and exposure history. This is technically a mass tort rather than a single class action, but the multi-district consolidation makes it operate similarly for plaintiffs.

In re Roundup Products Liability Litigation, MDL No. 2741 · N.D. Cal.

Who's eligible

People diagnosed with non-Hodgkin's lymphoma or related cancers who can document significant Roundup exposure (residential or occupational). Statutes of limitations vary by state — typically 2-4 years from diagnosis.

Not legal advice. Eligibility and payout details are summarized from public court records and official settlement websites. Always verify deadlines and submit claims through the official settlement website above.